All lobbying filings

MEHLMAN CONSULTING, INC.

Lobbying for VIZIENT INC · Healthcare services company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Government bodies contacted 3

HOUSE OF REPRESENTATIVES
Office of Management & Budget (OMB)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

340b drug pricing program. Issues related to pharmacy benefit manager reform. Health care workforce. Health care supply chain. Health care drug shortages.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.